Intradiscal Biacuplasty Helps Lumbar Pain

Article

Surgery appears to work better than conventional medical management to treat discogenic lumbar back pain, team reported at the American Society of Interventional Pain Physicians meeting in Orlando, FL.

Surgery appears to work better than conventional medical management to treat discogenic lumbar back pain, a team reported at the American Society of Interventional Pain Physicians meeting in Orlando, FL.

In a study presented at the meeting April 11, Mehul Desai, MD, MPH and colleagues at George Washington University Hospital, Washington, DC; Bloomington, IL; the Cleveland Clinic, Cleveland, OH; Arlington, TX; Orlando, FL; and the University of Washington Medical Center in Seattle, WA, evaluated the efficacy of intradiscal biacuplasty.

Patients who had the surgery and controls were rated on standard pain scales, physical functioning scales, a depression inventory, patients’ global impression of change, and health-related quality of life.

The assessments were done at intervals of 1 month, 3 months, and 6 months.

They found that pain was reduced by 2.4 points on the VAS score in those who had surgery versus .56 points in those who had conventional treatment.

The proportion of treatment responders was substantially greater in the surgery group (50% vs. 18%)

In addition, patients who had surgery had better improvements in depression and quality of life than those getting medications.

There were no significant differences in opioid use in the 2 groups, the team said.

The investigators, with one exception, are consultants for Halyard Health, Inc. (formerly Kimberly-Clark Health Care.)

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.